Table 1.
Anthropometric and clinical baseline characteristic of study subjects.
| Parameter (n = 24) | Male | Female | ||||
|---|---|---|---|---|---|---|
| Frequency (n, %) | (n = 14; 53.8%) | (n = 10; 41.7%) | ||||
| Median | P25 | P75 | Median | P25 | P75 | |
| Age (years) | 56.50 | 52.00 | 60.50 | 47.50 | 41.25 | 56.25 |
| SBP (mmHg) | 125.50 | 112.25 | 140.00 | 108.00 | 101.75 | 121.50 |
| DBP (mmHg) | 74.50 | 65.00 | 88.25 | 72.50 | 63.75 | 75.50 |
| Height (cm) | 172.00 | 165.00 | 173.25 | 161.00 | 155.75 | 162.00 |
| Weight (kg) | 75.00 | 69.50 | 82.95 | 63.95 | 58.83 | 78.68 |
| BMI (kg/m2) | 26.23 | 24.34 | 27.36 | 25.37 | 22.99 | 30.07 |
| Neck circumference (cm) | 41.00 | 39.75 | 42.63 | 37.00 | 35.38 | 38.25 |
| Waist circumference (cm) | 88.50 | 82.75 | 92.25 | 81.50 | 72.00 | 85.88 |
| Abdominal circumference (cm) | 94.00 | 87.13 | 97.00 | 92.75 | 86.75 | 99.75 |
| Hip circumference (cm) | 97.50 | 94.00 | 99.25 | 100.50 | 96.00 | 114.13 |
| Waist/hip ratio | 0.91 | 0.87 | 0.96 | 0.79 | 0.73 | 0.84 |
| TBFat (kg) | 19.30 | 16.20 | 22.60 | 22.90 | 20.51 | 37.41 |
| TBFat (%) | 25.60 | 22.28 | 28.58 | 38.45 | 33.05 | 42.28 |
| ABFat (%) | 33.15 | 25.08 | 37.53 | 43.00 | 33.98 | 51.75 |
| GBFat (%) | 25.70 | 22.98 | 27.15 | 39.35 | 36.88 | 49.63 |
| TBLean (kg) | 53.94 | 48.04 | 58.36 | 38.39 | 36.44 | 40.93 |
| BMC (g) | 2896.00 | 2631.75 | 3108.50 | 2313.00 | 2059.50 | 2634.75 |
| ASMMI | 8.74 | 8.37 | 9.29 | 6.67 | 6.42 | 7.59 |
| t-score | -0.40 | -0.93 | 0.13 | 0.25 | -1.13 | 1.60 |
| Neutrophils (K/μL) | 2850.00 | 2000.00 | 3530.00 | 3070.00 | 2190.00 | 3360.00 |
| Lymphocytes (K/μL) | 1800.00 | 1240.00 | 2000.00 | 2120.00 | 1160.00 | 2540.00 |
| Platelets (K/μL) | 191000.00 | 167000.00 | 204000.00 | 243000.00 | 173000.00 | 256000.00 |
| TC (mg/dL) | 193.00 | 149.00 | 245.00 | 214.00 | 159.00 | 270.00 |
| HDL-C (mg/dL) | 50.00 | 43.00 | 66.00 | 67.00 | 38.00 | 70.00 |
| LDL-C (mg/dL) | 131.00 | 80.00 | 159.00 | 146.00 | 75.00 | 178.00 |
| Tg (mg/dL) | 95.00 | 42.00 | 113.00 | 99.00 | 54.00 | 124.00 |
| NLR | 1.46 | 1.11 | 2.40 | 1.52 | 0.83 | 2.22 |
| PLR | 120.00 | 77.78 | 129.41 | 106.60 | 65.04 | 186.72 |
| Tg/HDL-C | 1.44 | 0.68 | 2.51 | 1.81 | 0.77 | 2.24 |
| TC/HDL-C | 3.86 | 2.40 | 4.00 | 3.87 | 2.34 | 4.07 |
| kcal/diet | 1960.00 | 1650.00 | 2050.00 | 1840.00 | 1230.00 | 2050.00 |
Anthropometric and clinical characteristic at baseline (T0) and after HNT (T1). Results are expressed as the median, minimum, and maximum for each parameter. A paired t-test (a) or a nonparametric Wilcoxon test (b) was performed to evaluate differences before and after hazelnut intervention. All tests were considered significant at p ≤ 0.05. SBP: systolic blood pressure; DBP: diastolic blood pressure; TBFat: total body fat; ABFat: android body fat; GBFat: gynoid body fat; TBLean: total body lean; BMC: bone mineral content; ASMMI: appendicular skeletal muscle mass index; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Tg: triglycerides; NLR: neutrophil-lymphocyte ratio; PLR: platelet-lymphocyte ratio.